PHAT Performance & Benchmarks - -27% in 12m
The Total Return for 3m is 148.5%, for 6m 48.3% and YTD 2.8%. Compare with Peer-Group: Pharmaceuticals
Performance Rating
-74.66%
#152 in Peer-Group
Rel. Strength
20.27%
#6129 in Stock-Universe
Total Return 12m
-26.95%
#137 in Peer-Group
Total Return 5y
-75.53%
#131 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 19.50 USD |
| 52 Week Low | 2.29 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 36.77 |
| Buy/Sell Signal +-5 | -0.11 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: PHAT (-27%) vs XLV (-11.8%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Short Term Performance
| Symbol | 1w | 1m | 3m |
|---|---|---|---|
| PHAT | -13.3% | -5.65% | 149% |
| SCLX | 12.1% | 122% | 163% |
| NMRA | -33.6% | 96.0% | 102% |
| KALA | -7.29% | 55.0% | 102% |
Long Term Performance
| Symbol | 6m | 12m | 5y |
|---|---|---|---|
| PHAT | 48.3% | -27% | -75.5% |
| VRNA | 78.3% | 365% | 1,479% |
| AMLX | 126% | 273% | -57.3% |
| ALTS | 3.80% | 303% | 48.8% |
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-0.45% | 81.9% | 350% | 58.4 | 54.6 | 0.61 | 32.2% | -1.12% |
| NVS NYSE Novartis |
-6.34% | 6.56% | 78.4% | 17.1 | 13.3 | 1.28 | 58.9% | - |
| LLY NYSE Eli Lilly |
-1.75% | -7.8% | 429% | 65.5 | 36.6 | 1.23 | 61.9% | 42.8% |
| NOVN SW Novartis |
-3.79% | 0.98% | 56.8% | 17.3 | 13.3 | 1.27 | 63.7% | 33.2% |
| GSK NYSE GlaxoSmithKline |
-3.57% | -1.07% | 43% | 17.6 | 8.89 | 0.39 | -13.7% | 23.9% |
| AZN NASDAQ AstraZeneca |
3.48% | -7.09% | 46% | 28.9 | 16 | 0.96 | 61.2% | 98.6% |
| SOBI ST Swedish Orphan Biovitrum |
-7.29% | -4.89% | 47.4% | 22.3 | 20 | 1.84 | 19.8% | 42.6% |
| ZEG XETRA AstraZeneca |
6.04% | -12.4% | 45.7% | 29 | 16.7 | 1 | 60.5% | 101% |
Performance Comparison: PHAT vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for PHAT
| Total Return (including Dividends) | PHAT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -5.65% | -4.08% | 0.66% |
| 3 Months | 148.51% | -3.57% | 11.66% |
| 12 Months | -26.95% | -11.78% | 15.92% |
| 5 Years | -75.53% | 33.11% | 103.09% |
| Trend Stabilty (consistency of price movement) | PHAT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -31.8% | -29.7% | 66.4% |
| 3 Months | 61.2% | 25% | 96.6% |
| 12 Months | -62.8% | -83% | 50% |
| 5 Years | -75.6% | 86.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | 24 %th | -1.63% | -6.27% |
| 3 Month | 99 %th | 157.72% | 122.57% |
| 12 Month | 33 %th | -17.20% | -36.98% |
| 5 Years | 34 %th | -81.62% | -87.95% |
FAQs
Does Phathom (PHAT) outperform the market?
No,
over the last 12 months PHAT made -26.95%, while its related Sector, the Health Care Sector SPDR (XLV) made -11.78%.
Over the last 3 months PHAT made 148.51%, while XLV made -3.57%.
Performance Comparison PHAT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PHAT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -10.9% | -6.3% | 43.7% | -43% |
| US NASDAQ 100 | QQQ | -11.1% | -6.9% | 41.1% | -48% |
| German DAX 40 | DAX | -10% | -4.6% | 39.4% | -56% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.7% | -8.3% | 39.4% | -48% |
| Hongkong Hang Seng | HSI | -11.1% | -7.8% | 21% | -66% |
| India NIFTY 50 | INDA | -11.3% | -0.1% | 44.7% | -20% |
| Brasil Bovespa | EWZ | -12.2% | 1.8% | 41.4% | -31% |
PHAT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -11.9% | -4.1% | 44.3% | -52% |
| Consumer Discretionary | XLY | -9.4% | -4.7% | 53.5% | -46% |
| Consumer Staples | XLP | -11.7% | -3.4% | 46% | -32% |
| Energy | XLE | -11.6% | -5.8% | 49.7% | -24% |
| Financial | XLF | -9.5% | -3.3% | 47.3% | -48% |
| Health Care | XLV | -9.4% | -1.6% | 58.6% | -15% |
| Industrial | XLI | -9.9% | -6.8% | 38.3% | -48% |
| Materials | XLB | -7.2% | -1.9% | 49.8% | -23% |
| Real Estate | XLRE | -9.8% | -4.7% | 46.9% | -29% |
| Technology | XLK | -11.4% | -8.1% | 35% | -50% |
| Utilities | XLU | -14.8% | -10.4% | 37.2% | -46% |
| Aerospace & Defense | XAR | -10.5% | -9.8% | 25.6% | -73% |
| Biotech | XBI | -11.4% | -9.1% | 54.3% | -14% |
| Homebuilder | XHB | -10.8% | -6.8% | 49.6% | -18% |
| Retail | XRT | -8.5% | -3.7% | 49% | -30% |
PHAT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -16.8% | -10.4% | 48.8% | -28% |
| Natural Gas | UNG | -11.8% | 4.2% | 71.1% | -31% |
| Gold | GLD | -13.9% | -6.2% | 29.4% | -64% |
| Silver | SLV | -10.2% | -8.3% | 31.2% | -56% |
| Copper | CPER | 9.8% | 7% | 46.8% | -35% |
PHAT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -14.9% | -5.3% | 46.9% | -23% |
| iShares High Yield Corp. Bond | HYG | -12.7% | -5.4% | 44.9% | -35% |